Vanguard Group Inc Anixa Biosciences Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,392,906 shares of ANIX stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,392,906
Previous 1,392,906
-0.0%
Holding current value
$4.23 Million
Previous $4.39 Million
21.27%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ANIX
# of Institutions
62Shares Held
5.73MCall Options Held
7.1KPut Options Held
26.7K-
D.A. Davidson & Co.671KShares$2.04 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.89 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.62 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.43 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA329KShares$1 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $93.2M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...